NovoCure Ltd — Director's Dealing 2018

Aug 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-08-02

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-02	Ordinary Shares	J	187787	$0.00	Disposed	438167	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	912143	Direct
Ordinary Shares	43000	Indirect

Footnotes

F1: On August 2, 2018, WFD-GP II LLC distributed to certain of its economic members 187,787 of the Issuer's shares. None of the shares were distributed to Mr. Doyle.

F2: Mr. Doyle is the Managing Director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.